Outcomes of enfortumab vedotin (EV) therapy in relation to prior immune checkpoint inhibitor (ICI) in patients (pts) with advanced urothelial cancer (aUC).
| Autor: | Vlachou, Evangelia, Elias, Roy, Hahn, Noah M., McConkey, David James, Johnson, Burles Avner, Hoffman-Censits, Jean H. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p570-570, 193p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|